
    
      All activities related to this human subjects research have been guided by ethical principles
      and have been reviewed and approved Federalwide Assurance National Ctr for Hematology,
      FWA00006482. The goal of the trial is to evaluate plasma concentration of proinflammatory
      cytokine interleukin-6 and the antiinflammatory cytokine interleukin-10, plasma levels of
      blood creatinine, bilirubin, procalcitonin, C-reactive protein. Then we will evaluate
      requirement for renal replacement therapy, requirement for mechanical ventilation or
      non-invasive mechanical ventilation, pulmonary function-coefficient, partial oxygen pressure
      arterial blood level, electrocardiograms, Kaplan - Meier curve,28-days mortality.
    
  